Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001214659-25-014813·CRESCENT BIOPHARMA, INC.
Schedule 13G ownership disclosure
CRESCENT BIOPHARMA INC.
Ordinary Shares, $0.001 par value per share · CUSIP: G2545C104
Event date: 2025-10-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 700,000.00 · Class: 5.04%
- KEVIN TANG
Shares: 700,000.00 · Class: 5.04%
- TANG CAPITAL PARTNERS, LP
Shares: 393,681.00 · Class: 2.84%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 306,319.00 · Class: 2.20%
- TANG CAPITAL PARTNERS III, INC
Shares: 0.00 · Class: 0.0%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-014813
- Form type
- SCHEDULE 13G
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Oct 09, 2025
- Reporting period
- Oct 02, 2025
- Description
- Schedule 13G beneficial ownership